4 Oncology Stocks To Consider As Biotech Companies Escalate Their Fight Against Cancer

Given the devastating toll associated with cancer, the author of today’s article notes that “biotech companies are under pressure to develop effective drugs to combat the disease. They have been conducting multiple clinical trials to extend cancer patients’ survival rates and duration of response and are adopting advanced technologies in immunotherapies to capitalize on the heightened need for cancer treatments.” With that, she proceeds to examine four oncology stocks that could be smart picks right now. For more, CLICK HERE.